Skip to main content
Erschienen in: Rheumatology International 3/2019

10.11.2018 | Patient Opinion

Self-reported disease severity in women with systemic lupus erythematosus

verfasst von: A. Dima, S. Caraiola, C. Delcea, R. A. Ionescu, C. Jurcut, C. Badea

Erschienen in: Rheumatology International | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Systemic lupus erythematosus (SLE), pathology with net feminine predominance, is one of the most complex autoimmune diseases and has major impact on patients’ life. The aim is to identify patient and disease-related factors associated with self-perceived disease severity in female SLE patients. This cross-sectional study enrolled 73 women fulfilling the 2012 Systemic Lupus International Collaborating Clinic (SLICC) criteria. SLE disease activity was assessed by the Systemic Lupus Activity Measure (SLAM) score and overall damage by the SLICC/American College of Rheumatology (ACR) index. Patients’ general characteristics, associated conditions as well as SLE specific clinical involvements and therapeutic principles were also noted. Fatigue was assessed by FACIT-fatigue scale. Self-perceived disease severity was assessed using numerical rating scales (1–10 NRSs), to evaluate the disease severity at inclusion (1–10 NRS now) and worst severity anytime during disease history (1–10 NRS worst ever). In regard to worst ever lupus severity, 54.8% of patients responded with 9 or 10, while none with 1 or 2 even if only 22.9% of the patients responded with 7 or more for disease severity at inclusion (1–10 NRS now). Women with higher 1–10 NRS now answers had also higher 1–10 NRS worst ever, SLAM, SLICC, and FACIT-fatigue scores. They associated more frequently anxiety/depression diagnosis, antiphospholipid syndrome, joint involvement as well as treatments with corticosteroids. Self-reported disease severity worst ever, anxiety/depression diagnosis, fatigue, and the daily dose of corticosteroids were independently associated with patients’ perception on lupus severity at inclusion: OR (95% CI), 2.13 (1.15–3.94) p = 0.017, 6.67 (1.11–39.97) p = 0.038, 1.10 (1.02–1.19) p = 0.018, and 1.11 (1.02–1.21) p = 0.020, respectively. The vast majority of patients identified severe and very severe events during their disease history, results that raise awareness of burden concerning lupus occurrence in women’s life. Self-perceived lupus severity is multifactorial, influenced also by factors less considered in the SLE management like fatigue and the depression/anxiety disorders, but also by the previous patient’s experience.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Fatoye F, Gebrye T, Svenson LW (2018) Real-world incidence and prevalence of systemic lupus erythematosus in Alberta, Canada. Rheumatol Int 38(9):1721–1726CrossRefPubMedPubMedCentral Fatoye F, Gebrye T, Svenson LW (2018) Real-world incidence and prevalence of systemic lupus erythematosus in Alberta, Canada. Rheumatol Int 38(9):1721–1726CrossRefPubMedPubMedCentral
2.
3.
Zurück zum Zitat Kiani AN, Strand V, Fang H, Jaranilla J, Petri M (2013) Predictors of self-reported health-related quality of life in systemic lupus erythematosus. Rheumatology 52(9):1651–1657CrossRefPubMedPubMedCentral Kiani AN, Strand V, Fang H, Jaranilla J, Petri M (2013) Predictors of self-reported health-related quality of life in systemic lupus erythematosus. Rheumatology 52(9):1651–1657CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Björk M, Dahlström Ö, Wetterö J, Sjöwall C (2015) Quality of life and acquired organ damage are intimately related to activity limitations in patients with systemic lupus erythematosus. BMC Musculoskelet Disord 16(1):188CrossRefPubMedPubMedCentral Björk M, Dahlström Ö, Wetterö J, Sjöwall C (2015) Quality of life and acquired organ damage are intimately related to activity limitations in patients with systemic lupus erythematosus. BMC Musculoskelet Disord 16(1):188CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Boomsma MM, Bijl M, Stegeman CA, Kallenberg CGM, Hoffman GS, Tervaert JWC (2002) Patients’ perceptions of the effects of systemic lupus erythematosus on health, function, income, and interpersonal relationships: a comparison with Wegener’s granulomatosis. Arthritis Rheum 47(2):196–201CrossRefPubMed Boomsma MM, Bijl M, Stegeman CA, Kallenberg CGM, Hoffman GS, Tervaert JWC (2002) Patients’ perceptions of the effects of systemic lupus erythematosus on health, function, income, and interpersonal relationships: a comparison with Wegener’s granulomatosis. Arthritis Rheum 47(2):196–201CrossRefPubMed
6.
Zurück zum Zitat Castrejón I, Yazici Y, Samuels J, Luta G, Pincus T (2014) Discordance of global estimates by patients and their physicians in usual care of many rheumatic diseases: association with 5 scores on a Multidimensional Health Assessment Questionnaire (MDHAQ) that are not found on the Health Assessment Questionnaire (HAQ). Arthritis Care Res (Hoboken) 66(6):934–942CrossRef Castrejón I, Yazici Y, Samuels J, Luta G, Pincus T (2014) Discordance of global estimates by patients and their physicians in usual care of many rheumatic diseases: association with 5 scores on a Multidimensional Health Assessment Questionnaire (MDHAQ) that are not found on the Health Assessment Questionnaire (HAQ). Arthritis Care Res (Hoboken) 66(6):934–942CrossRef
7.
Zurück zum Zitat Leong KP, Chong EYY, Kong KO, Chan SP, Thong BYH, Lian TY et al (2010) Discordant assessment of lupus activity between patients and their physicians: the Singapore experience. Lupus 19(1):100–106CrossRefPubMed Leong KP, Chong EYY, Kong KO, Chan SP, Thong BYH, Lian TY et al (2010) Discordant assessment of lupus activity between patients and their physicians: the Singapore experience. Lupus 19(1):100–106CrossRefPubMed
8.
Zurück zum Zitat Jolly M, Kosinski M, Garris CP, Oglesby AK (2016) Prospective validation of the lupus impact tracker: a patient-completed tool for clinical practice to evaluate the impact of systemic lupus erythematosus. Arthritis Rheumatol 68(6):1422–1431CrossRefPubMed Jolly M, Kosinski M, Garris CP, Oglesby AK (2016) Prospective validation of the lupus impact tracker: a patient-completed tool for clinical practice to evaluate the impact of systemic lupus erythematosus. Arthritis Rheumatol 68(6):1422–1431CrossRefPubMed
9.
Zurück zum Zitat Stoll T, Sutcliffe N, Mach J, Klaghofer R, Isenberg DA (2004) Analysis of the relationship between disease activity and damage in patients with systemic lupus erythematosus–a 5-yr prospective study. Rheumatology 43(8):1039–1044CrossRefPubMed Stoll T, Sutcliffe N, Mach J, Klaghofer R, Isenberg DA (2004) Analysis of the relationship between disease activity and damage in patients with systemic lupus erythematosus–a 5-yr prospective study. Rheumatology 43(8):1039–1044CrossRefPubMed
10.
Zurück zum Zitat Larsen JL, Hall EOC, Jacobsen S, Birkelund R (2018) The existential experience of everyday life with systemic lupus erythematosus. J Adv Nurs 74(5):1170–1179CrossRefPubMed Larsen JL, Hall EOC, Jacobsen S, Birkelund R (2018) The existential experience of everyday life with systemic lupus erythematosus. J Adv Nurs 74(5):1170–1179CrossRefPubMed
11.
Zurück zum Zitat Palominos PE, Gasparin AA, de Andrade NPB, Xavier RM, da Silva Chakr RM, Igansi F et al (2018) Fears and beliefs of people living with rheumatoid arthritis: a systematic literature review. Adv Rheumatol 58(1):1CrossRefPubMed Palominos PE, Gasparin AA, de Andrade NPB, Xavier RM, da Silva Chakr RM, Igansi F et al (2018) Fears and beliefs of people living with rheumatoid arthritis: a systematic literature review. Adv Rheumatol 58(1):1CrossRefPubMed
12.
Zurück zum Zitat Phuti A, Schneider M, Tikly M, Hodkinson B (2018) Living with systemic lupus erythematosus in the developing world. Rheumatol Int 38(9):1601–1613CrossRefPubMed Phuti A, Schneider M, Tikly M, Hodkinson B (2018) Living with systemic lupus erythematosus in the developing world. Rheumatol Int 38(9):1601–1613CrossRefPubMed
13.
Zurück zum Zitat Hjermstad MJ, Fayers PM, Haugen DF, Caraceni A, Hanks GW, Loge JH et al (2011) Studies comparing numerical rating scales, verbal rating scales, and visual analogue scales for assessment of pain intensity in adults: a systematic literature review. J Pain Symptom Manage 41:1073–1093CrossRefPubMed Hjermstad MJ, Fayers PM, Haugen DF, Caraceni A, Hanks GW, Loge JH et al (2011) Studies comparing numerical rating scales, verbal rating scales, and visual analogue scales for assessment of pain intensity in adults: a systematic literature review. J Pain Symptom Manage 41:1073–1093CrossRefPubMed
14.
Zurück zum Zitat Chien C-W, Bagraith KS, Khan A, Deen M, Strong J (2013) Comparative responsiveness of verbal and numerical rating scales to measure pain intensity in patients with chronic pain. J Pain 14(12):1653–1662CrossRefPubMed Chien C-W, Bagraith KS, Khan A, Deen M, Strong J (2013) Comparative responsiveness of verbal and numerical rating scales to measure pain intensity in patients with chronic pain. J Pain 14(12):1653–1662CrossRefPubMed
15.
Zurück zum Zitat Petri M, Orbai AM, Alarcon GS, Gordon C, Merrill JT, Fortin PR et al (2012) Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64(8):2677–2686CrossRefPubMedPubMedCentral Petri M, Orbai AM, Alarcon GS, Gordon C, Merrill JT, Fortin PR et al (2012) Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64(8):2677–2686CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Bertoli AM, Alarcón GS, McGwin G, Fernández M, Bastian HM, Fessler BJ et al (2006) Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XXVII: factors predictive of a decline to low levels of disease activity. Lupus 15(1):13–18CrossRefPubMed Bertoli AM, Alarcón GS, McGwin G, Fernández M, Bastian HM, Fessler BJ et al (2006) Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XXVII: factors predictive of a decline to low levels of disease activity. Lupus 15(1):13–18CrossRefPubMed
17.
Zurück zum Zitat Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M et al (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39(3):363–369CrossRefPubMed Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M et al (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39(3):363–369CrossRefPubMed
18.
Zurück zum Zitat Kosinski M, Gajria K, Fernandes A, Cella D (2013) Qualitative validation of the FACIT-Fatigue scale in systemic lupus erythematosus. Lupus 22(5):422–430CrossRefPubMed Kosinski M, Gajria K, Fernandes A, Cella D (2013) Qualitative validation of the FACIT-Fatigue scale in systemic lupus erythematosus. Lupus 22(5):422–430CrossRefPubMed
19.
Zurück zum Zitat Mikdashi J, Nived O (2015) Measuring disease activity in adults with systemic lupus erythematosus: the challenges of administrative burden and responsiveness to patient concerns in clinical research. Arthritis Res Ther 17(1):183CrossRefPubMedPubMedCentral Mikdashi J, Nived O (2015) Measuring disease activity in adults with systemic lupus erythematosus: the challenges of administrative burden and responsiveness to patient concerns in clinical research. Arthritis Res Ther 17(1):183CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Schneider M, Mosca M, Pego-Reigosa JM, Hachulla E, Teh L-S, Perna A et al (2015) Understanding remission in real-world lupus patients across five European countries. Lupus 25(5):505–512CrossRefPubMed Schneider M, Mosca M, Pego-Reigosa JM, Hachulla E, Teh L-S, Perna A et al (2015) Understanding remission in real-world lupus patients across five European countries. Lupus 25(5):505–512CrossRefPubMed
21.
Zurück zum Zitat Wang S, Hsieh E, Zhu L, Wu B, Lu L (2015) Comparative assessment of different health utility measures in systemic lupus erythematosus. Sci Rep 5:13297CrossRefPubMedPubMedCentral Wang S, Hsieh E, Zhu L, Wu B, Lu L (2015) Comparative assessment of different health utility measures in systemic lupus erythematosus. Sci Rep 5:13297CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Georgopoulou S, Prothero L, D’Cruz DP (2018) Physician–patient communication in rheumatology: a systematic review. Rheumatol Int 38(5):763–775CrossRefPubMedPubMedCentral Georgopoulou S, Prothero L, D’Cruz DP (2018) Physician–patient communication in rheumatology: a systematic review. Rheumatol Int 38(5):763–775CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Nowicka-Sauer K, Pietrzykowska M, Banaszkiewicz D, Hajduk A, Czuszyńska Z, Smoleńska Ż (2016) How do patients and doctors-to-be perceive systemic lupus erythematosus? Rheumatol Int 36(5):725–729CrossRefPubMed Nowicka-Sauer K, Pietrzykowska M, Banaszkiewicz D, Hajduk A, Czuszyńska Z, Smoleńska Ż (2016) How do patients and doctors-to-be perceive systemic lupus erythematosus? Rheumatol Int 36(5):725–729CrossRefPubMed
24.
Zurück zum Zitat Neville C, Clarke AE, Joseph L, Belisle P, Ferland D, Fortin PR (2000) Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity. J Rheumatol 27:675–679PubMed Neville C, Clarke AE, Joseph L, Belisle P, Ferland D, Fortin PR (2000) Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity. J Rheumatol 27:675–679PubMed
25.
Zurück zum Zitat Ng X, dosReis S, Beardsley R, Magder L, Mullins CD, Petri M (2018) Understanding systemic lupus erythematosus patients’ desired outcomes and their perceptions of the risks and benefits of using corticosteroids. Lupus 27(3):475–483CrossRefPubMed Ng X, dosReis S, Beardsley R, Magder L, Mullins CD, Petri M (2018) Understanding systemic lupus erythematosus patients’ desired outcomes and their perceptions of the risks and benefits of using corticosteroids. Lupus 27(3):475–483CrossRefPubMed
26.
Zurück zum Zitat Serrano-Aguilar P, Trujillo-Martin M, del M, Perez, de la Rosa A, Cuellar-Pompa L, Saavedra-Medina H, Linertova R et al (2015) Patient participation in a clinical guideline development for systemic lupus erythematosus. Patient Educ Couns 98(9):1156–1163CrossRefPubMed Serrano-Aguilar P, Trujillo-Martin M, del M, Perez, de la Rosa A, Cuellar-Pompa L, Saavedra-Medina H, Linertova R et al (2015) Patient participation in a clinical guideline development for systemic lupus erythematosus. Patient Educ Couns 98(9):1156–1163CrossRefPubMed
27.
Zurück zum Zitat Pettersson S, Lövgren M, Eriksson LE, Moberg C, Svenungsson E, Gunnarsson I et al (2012) An exploration of patient-reported symptoms in systemic lupus erythematosus and the relationship to health-related quality of life. Scand J Rheumatol 41(5):383–390CrossRefPubMed Pettersson S, Lövgren M, Eriksson LE, Moberg C, Svenungsson E, Gunnarsson I et al (2012) An exploration of patient-reported symptoms in systemic lupus erythematosus and the relationship to health-related quality of life. Scand J Rheumatol 41(5):383–390CrossRefPubMed
28.
Zurück zum Zitat Fonseca R, Bernardes M, Terroso G, De Sousa M, Figueiredo-Braga M (2014) Silent burdens in disease: fatigue and depression in SLE. Autoimmune Dis 2014:790724PubMedPubMedCentral Fonseca R, Bernardes M, Terroso G, De Sousa M, Figueiredo-Braga M (2014) Silent burdens in disease: fatigue and depression in SLE. Autoimmune Dis 2014:790724PubMedPubMedCentral
29.
Zurück zum Zitat Burgos PI, Alarcón GS, McGwin G, Crews KQ, Reveille JD, Vilá LM (2009) Disease activity and damage are not associated with increased levels of fatigue in systemic lupus erythematosus patients from a multiethnic cohort: LXVII. Arthritis Rheum 61(9):1179–1186CrossRefPubMedPubMedCentral Burgos PI, Alarcón GS, McGwin G, Crews KQ, Reveille JD, Vilá LM (2009) Disease activity and damage are not associated with increased levels of fatigue in systemic lupus erythematosus patients from a multiethnic cohort: LXVII. Arthritis Rheum 61(9):1179–1186CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Barbasio C, Vagelli R, Marengo D, Querci F, Settanni M, Tani C et al (2015) Illness perception in systemic lupus erythematosus patients: The roles of alexithymia and depression. Compr Psychiatry 63:88–95CrossRefPubMed Barbasio C, Vagelli R, Marengo D, Querci F, Settanni M, Tani C et al (2015) Illness perception in systemic lupus erythematosus patients: The roles of alexithymia and depression. Compr Psychiatry 63:88–95CrossRefPubMed
32.
Zurück zum Zitat Lemaire B, Geron D, Malaise O, Krzesinski JM, Ansseau M, Scantamburlo G (2015) Depression as a common complication of systemic lupus erythematosus. Rev médicale Liège 70:215–218 Lemaire B, Geron D, Malaise O, Krzesinski JM, Ansseau M, Scantamburlo G (2015) Depression as a common complication of systemic lupus erythematosus. Rev médicale Liège 70:215–218
33.
Zurück zum Zitat Braga J, Campar A (2014) Biological causes of depression in systemic lupus. Erythematosus Acta Reum Port 39:218–226 Braga J, Campar A (2014) Biological causes of depression in systemic lupus. Erythematosus Acta Reum Port 39:218–226
34.
Zurück zum Zitat Huang X, Magder LS, Petri M (2014) Predictors of incident depression in systemic lupus erythematosus. J Rheumatol 41:1823–1833CrossRefPubMed Huang X, Magder LS, Petri M (2014) Predictors of incident depression in systemic lupus erythematosus. J Rheumatol 41:1823–1833CrossRefPubMed
35.
Zurück zum Zitat Fraenkel L, Bogardus S, Concato J (2002) Patient preferences for treatment of lupus nephritis. Arthritis Rheum 47(4):421–428CrossRefPubMed Fraenkel L, Bogardus S, Concato J (2002) Patient preferences for treatment of lupus nephritis. Arthritis Rheum 47(4):421–428CrossRefPubMed
36.
Zurück zum Zitat Bexelius C, Wachtmeister K, Skare P, Jönsson L, Vollenhoven R van (2013) Drivers of cost and health-related quality of life in patients with systemic lupus erythematosus (SLE): a Swedish nationwide study based on patient reports. Lupus 22(8):793–801CrossRefPubMed Bexelius C, Wachtmeister K, Skare P, Jönsson L, Vollenhoven R van (2013) Drivers of cost and health-related quality of life in patients with systemic lupus erythematosus (SLE): a Swedish nationwide study based on patient reports. Lupus 22(8):793–801CrossRefPubMed
Metadaten
Titel
Self-reported disease severity in women with systemic lupus erythematosus
verfasst von
A. Dima
S. Caraiola
C. Delcea
R. A. Ionescu
C. Jurcut
C. Badea
Publikationsdatum
10.11.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 3/2019
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-018-4203-1

Weitere Artikel der Ausgabe 3/2019

Rheumatology International 3/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.